Filtros : "Emirados Árabes Unidos" "Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)" "FCF" Removidos: "Issa, Fabiana Inácio da Costa" "Liu, Yongjian" "ICB-BMP" "PARTE DE MONOGRAFIA/LIVRO-APRES/PREF/POSF" Limpar

Filtros



Refine with date range


  • Source: Current Medicinal Chemistry. Unidade: FCF

    Subjects: TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS, DESENVOLVIMENTO DE PRODUTOS, PRODUTOS NOVOS, FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PRATES, João Lucas Bruno et al. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, v. 31, n. 16, p. 2285-2308, 2024Tradução . . Disponível em: https://dx.doi.org/10.2174/0109298673254864230921090. Acesso em: 27 ago. 2024.
    • APA

      Prates, J. L. B., Lopes, J. R., Chin, C. M., Ferreira, E. I., Santos, J. L. dos, & Scarim, C. B. (2024). Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi. Current Medicinal Chemistry, 31( 16), 2285-2308. doi:10.2174/0109298673254864230921090
    • NLM

      Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 ago. 27 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
    • Vancouver

      Prates JLB, Lopes JR, Chin CM, Ferreira EI, Santos JL dos, Scarim CB. Discovery of novel inhibitors of Cruzain cysteine protease of Trypanosoma cruzi [Internet]. Current Medicinal Chemistry. 2024 ; 31( 16): 2285-2308.[citado 2024 ago. 27 ] Available from: https://dx.doi.org/10.2174/0109298673254864230921090
  • Source: Letters in Drug Design & Discovery. Unidade: FCF

    Subjects: GLIOMA, SISTEMA NERVOSO CENTRAL

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERNANDES, Thais Batista et al. Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells. Letters in Drug Design & Discovery, v. 21, p. 948-960, 2024Tradução . . Disponível em: https://doi.org/10.2174/1570180820666230131111033. Acesso em: 27 ago. 2024.
    • APA

      Fernandes, T. B., Yang, R., Ferreira, G. M., Souza, P. O. de, Lopes, V. G., Toledo, M. F. Z. J., et al. (2024). Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells. Letters in Drug Design & Discovery, 21, 948-960. doi:10.2174/1570180820666230131111033
    • NLM

      Fernandes TB, Yang R, Ferreira GM, Souza PO de, Lopes VG, Toledo MFZJ, Roliano GG, Debom GN, Vassiliades SV, Hassimotto NMA, Hirata MH, Braganhol E, Parise Filho R. Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells [Internet]. Letters in Drug Design & Discovery. 2024 ; 21 948-960.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1570180820666230131111033
    • Vancouver

      Fernandes TB, Yang R, Ferreira GM, Souza PO de, Lopes VG, Toledo MFZJ, Roliano GG, Debom GN, Vassiliades SV, Hassimotto NMA, Hirata MH, Braganhol E, Parise Filho R. Aryl-isoquinoline as a potential scaffold for novel antitumor agents against glioblastoma cells [Internet]. Letters in Drug Design & Discovery. 2024 ; 21 948-960.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1570180820666230131111033
  • Source: Mini-Reviews in Medicinal Chemistry. Unidade: FCF

    Subjects: HOMEOSTASE, TUBERCULOSE, ÁCIDO FÓLICO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VASSILIADES, Sandra Valeria et al. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents. Mini-Reviews in Medicinal Chemistry, v. 23, n. 17, p. 1711-1732, 2023Tradução . . Disponível em: https://doi.org/10.2174/1389557523666230206163154. Acesso em: 27 ago. 2024.
    • APA

      Vassiliades, S. V., Borges, L. G., Giarolla, J., & Parise Filho, R. (2023). Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents. Mini-Reviews in Medicinal Chemistry, 23( 17), 1711-1732. doi:10.2174/1389557523666230206163154
    • NLM

      Vassiliades SV, Borges LG, Giarolla J, Parise Filho R. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents [Internet]. Mini-Reviews in Medicinal Chemistry. 2023 ; 23( 17): 1711-1732.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1389557523666230206163154
    • Vancouver

      Vassiliades SV, Borges LG, Giarolla J, Parise Filho R. Folate pathway inhibitors, an underestimated and underexplored molecular target for new anti-tuberculosis agents [Internet]. Mini-Reviews in Medicinal Chemistry. 2023 ; 23( 17): 1711-1732.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1389557523666230206163154
  • Source: Current Drug Targets. Unidade: FCF

    Subjects: FLAVONOIDES, MEDICAMENTO, DOENÇAS NEGLIGENCIADAS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PONE, Boniface Kamdem e FERREIRA, Elizabeth Igne. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial]. Current Drug Targets. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://doi.org/10.2174/1389450123666220309093827. Acesso em: 27 ago. 2024. , 2022
    • APA

      Pone, B. K., & Ferreira, E. I. (2022). Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial]. Current Drug Targets. Sharjah: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.2174/1389450123666220309093827
    • NLM

      Pone BK, Ferreira EI. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] [Internet]. Current Drug Targets. 2022 ; 23( 7): 680-682.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1389450123666220309093827
    • Vancouver

      Pone BK, Ferreira EI. Therapeutic potential of flavonoid derivatives for certain neglected tropical diseases [Editorial] [Internet]. Current Drug Targets. 2022 ; 23( 7): 680-682.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1389450123666220309093827
  • Source: Protein and Peptide Letters. Unidade: FCF

    Subjects: ZIKA VÍRUS, PEPTÍDEOS, MODELAGEM MOLECULAR

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, João Vitor da et al. Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides. Protein and Peptide Letters, v. 29, p. 901-910, 2022Tradução . . Disponível em: https://doi.org/10.2174/0929866529666220919143316. Acesso em: 27 ago. 2024.
    • APA

      Silva, J. V. da, Savino, D. F., Hirata, M. H., Ferreira, G. M., & Giarolla, J. (2022). Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides. Protein and Peptide Letters, 29, 901-910. doi:10.2174/0929866529666220919143316
    • NLM

      Silva JV da, Savino DF, Hirata MH, Ferreira GM, Giarolla J. Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides [Internet]. Protein and Peptide Letters. 2022 ; 29 901-910.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/0929866529666220919143316
    • Vancouver

      Silva JV da, Savino DF, Hirata MH, Ferreira GM, Giarolla J. Zika virus NS2B-NS3 protease: quantum chemical properties insights into designing inhibitory peptides [Internet]. Protein and Peptide Letters. 2022 ; 29 901-910.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/0929866529666220919143316
  • Source: Mini-Reviews in Medicinal Chemistry. Unidades: FCFRP, FCF

    Assunto: FÁRMACOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LIMA, Elys Juliane Cardoso et al. Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, v. 21, n. 16, p. 2227-2248, 2021Tradução . . Disponível em: https://doi.org/10.2174/1389557521666210226145328. Acesso em: 27 ago. 2024.
    • APA

      Lima, E. J. C., Gomes, R. A., Fornari, E., Emery, F. da S., & Trossini, G. H. G. (2021). Insights into newly approved drugs from a medicinal chemistry perspective. Mini-Reviews in Medicinal Chemistry, 21( 16), 2227-2248. doi:10.2174/1389557521666210226145328
    • NLM

      Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1389557521666210226145328
    • Vancouver

      Lima EJC, Gomes RA, Fornari E, Emery F da S, Trossini GHG. Insights into newly approved drugs from a medicinal chemistry perspective [Internet]. Mini-Reviews in Medicinal Chemistry. 2021 ; 21( 16): 2227-2248.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1389557521666210226145328
  • Source: Current Topics in Medicinal Chemistry. Unidade: FCF

    Subjects: PLASMODIUM FALCIPARUM, MALÁRIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PEREIRA, Pedro Henrique Scarpelli e PEREIRA, Lucas Borges e GARCIA, Célia Regina da Silva. Evidences of G-Coupled Protein Receptor (GPCR) signaling in the human malaria parasite Plasmodium falciparum for sensing its microenvironment and the role of purinergic signaling in malaria parasites. Current Topics in Medicinal Chemistry, v. 21, p. 171-180, 2021Tradução . . Disponível em: https://doi.org/10.2174/1568026620666200826122716. Acesso em: 27 ago. 2024.
    • APA

      Pereira, P. H. S., Pereira, L. B., & Garcia, C. R. da S. (2021). Evidences of G-Coupled Protein Receptor (GPCR) signaling in the human malaria parasite Plasmodium falciparum for sensing its microenvironment and the role of purinergic signaling in malaria parasites. Current Topics in Medicinal Chemistry, 21, 171-180. doi:10.2174/1568026620666200826122716
    • NLM

      Pereira PHS, Pereira LB, Garcia CR da S. Evidences of G-Coupled Protein Receptor (GPCR) signaling in the human malaria parasite Plasmodium falciparum for sensing its microenvironment and the role of purinergic signaling in malaria parasites [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 171-180.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1568026620666200826122716
    • Vancouver

      Pereira PHS, Pereira LB, Garcia CR da S. Evidences of G-Coupled Protein Receptor (GPCR) signaling in the human malaria parasite Plasmodium falciparum for sensing its microenvironment and the role of purinergic signaling in malaria parasites [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 171-180.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1568026620666200826122716
  • Source: Current Topics in Medicinal Chemistry. Unidade: FCF

    Subjects: TUBERCULOSE, ANTIBIÓTICOS, INIBIDORES DE ENZIMAS, QUIMIOTERAPIA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PRIMI, Marina Candido et al. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, v. 21, p. 1186-1197, 2021Tradução . . Disponível em: https://doi.org/10.2174/1568026621666210728094804. Acesso em: 27 ago. 2024.
    • APA

      Primi, M. C., Tavares, M. T., Klein, L. L., Izard, T., Sant'Anna, C. M. R., Franzblau, S. G., & Ferreira, E. I. (2021). Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis. Current Topics in Medicinal Chemistry, 21, 1186-1197. doi:10.2174/1568026621666210728094804
    • NLM

      Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1568026621666210728094804
    • Vancouver

      Primi MC, Tavares MT, Klein LL, Izard T, Sant'Anna CMR, Franzblau SG, Ferreira EI. Design of novel phosphopantetheine adenylyltransferase inhibitors: a potential new approach to tackle Mycobacterium tuberculosis [Internet]. Current Topics in Medicinal Chemistry. 2021 ; 21 1186-1197.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1568026621666210728094804
  • Source: Medicinal Chemistry. Unidade: FCF

    Subjects: AGENTES ANTIMICROBIANOS, ANTIOXIDANTES, RESISTÊNCIA MICROBIANA ÀS DROGAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERNANDES, Thais Batista et al. Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking. Medicinal Chemistry, v. 17, p. 474-484, 2021Tradução . . Disponível em: https://doi.org/10.2174/1573406415666191122111228. Acesso em: 27 ago. 2024.
    • APA

      Fernandes, T. B., Segretti, N. D., Lourenço, F. R., Cândido, T. M., Baby, A. R., Barbosa, E. G., & Parise Filho, R. (2021). Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking. Medicinal Chemistry, 17, 474-484. doi:10.2174/1573406415666191122111228
    • NLM

      Fernandes TB, Segretti ND, Lourenço FR, Cândido TM, Baby AR, Barbosa EG, Parise Filho R. Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking [Internet]. Medicinal Chemistry. 2021 ; 17 474-484.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1573406415666191122111228
    • Vancouver

      Fernandes TB, Segretti ND, Lourenço FR, Cândido TM, Baby AR, Barbosa EG, Parise Filho R. Design of arylsulfonylhydrazones as potential FabH inhibitors: synthesis, antimicrobial evaluation and molecular docking [Internet]. Medicinal Chemistry. 2021 ; 17 474-484.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1573406415666191122111228
  • Source: Anti-Cancer Agents in Medicinal Chemistry. Unidade: FCF

    Subjects: MELANOMA, AÇAFRÃO, METALOPROTEINASES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Nayane de et al. Metalloproteinases suppression driven by the curcumin analog dm-1 modulates invasion in braf-resistant melanomas. Anti-Cancer Agents in Medicinal Chemistry, v. 20, p. 1038-1050, 2020Tradução . . Disponível em: https://doi.org/10.2174/1871520620666200218111422. Acesso em: 27 ago. 2024.
    • APA

      Souza, N. de, Oliveira, E. A. de, Flores, F. F., Pimenta, L. de A., Quincoces, J. A. P., Sampaio, S. C., & Maria-Engler, S. S. (2020). Metalloproteinases suppression driven by the curcumin analog dm-1 modulates invasion in braf-resistant melanomas. Anti-Cancer Agents in Medicinal Chemistry, 20, 1038-1050. doi:10.2174/1871520620666200218111422
    • NLM

      Souza N de, Oliveira EA de, Flores FF, Pimenta L de A, Quincoces JAP, Sampaio SC, Maria-Engler SS. Metalloproteinases suppression driven by the curcumin analog dm-1 modulates invasion in braf-resistant melanomas [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2020 ; 20 1038-1050.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1871520620666200218111422
    • Vancouver

      Souza N de, Oliveira EA de, Flores FF, Pimenta L de A, Quincoces JAP, Sampaio SC, Maria-Engler SS. Metalloproteinases suppression driven by the curcumin analog dm-1 modulates invasion in braf-resistant melanomas [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2020 ; 20 1038-1050.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1871520620666200218111422
  • Source: Current Drug Targets. Unidade: FCF

    Subjects: FILARIOSE, DOENÇAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BONIFACE, Pone Kamdem e FERREIRA, Elizabeth Igne. An insight into the discovery of potent Antifilarial leads against lymphatic filariasis. Current Drug Targets, v. 21, p. 657-680, 2020Tradução . . Disponível em: https://doi.org/10.2174/1389450120666191204152415. Acesso em: 27 ago. 2024.
    • APA

      Boniface, P. K., & Ferreira, E. I. (2020). An insight into the discovery of potent Antifilarial leads against lymphatic filariasis. Current Drug Targets, 21, 657-680. doi:10.2174/1389450120666191204152415
    • NLM

      Boniface PK, Ferreira EI. An insight into the discovery of potent Antifilarial leads against lymphatic filariasis [Internet]. Current Drug Targets. 2020 ; 21 657-680.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1389450120666191204152415
    • Vancouver

      Boniface PK, Ferreira EI. An insight into the discovery of potent Antifilarial leads against lymphatic filariasis [Internet]. Current Drug Targets. 2020 ; 21 657-680.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1389450120666191204152415
  • Source: Current Drug Targets. Unidade: FCF

    Subjects: LEISHMANIA, FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BONIFACE, Pone Kamdem e SANO, Cinthya Miyuki e FERREIRA, Elizabeth Igne. Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods. Current Drug Targets, v. 21, p. 681-712, 2020Tradução . . Disponível em: https://doi.org/10.2174/1389450121666200128112948. Acesso em: 27 ago. 2024.
    • APA

      Boniface, P. K., Sano, C. M., & Ferreira, E. I. (2020). Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods. Current Drug Targets, 21, 681-712. doi:10.2174/1389450121666200128112948
    • NLM

      Boniface PK, Sano CM, Ferreira EI. Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods [Internet]. Current Drug Targets. 2020 ; 21 681-712.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1389450121666200128112948
    • Vancouver

      Boniface PK, Sano CM, Ferreira EI. Unveiling the targets involved in the quest of antileishmanial Leads using in silico methods [Internet]. Current Drug Targets. 2020 ; 21 681-712.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1389450121666200128112948
  • Source: Emirates Journal of Food and Agriculture. Unidade: FCF

    Subjects: CAJÁ, SORVETE, PROBIÓTICOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PAULA, Clara Mitia de et al. Fat substitution by inulin in goat milk ice cream produced with cajá (Spondias mombin) pulp and probiotic cultures: influence on composition, texture, and acceptability among consumers of two Brazilian regions. Emirates Journal of Food and Agriculture, v. 32 n. 2, p. 140-149, 2020Tradução . . Disponível em: https://doi.org/10.9755/ejfa.2020.v32.i2.2074. Acesso em: 27 ago. 2024.
    • APA

      Paula, C. M. de, Santos, K. M. O. dos, Oliveira, L. S., Oliveira, J. da S., Buriti, F. C. A., & Saad, S. M. I. (2020). Fat substitution by inulin in goat milk ice cream produced with cajá (Spondias mombin) pulp and probiotic cultures: influence on composition, texture, and acceptability among consumers of two Brazilian regions. Emirates Journal of Food and Agriculture, 32 n. 2, 140-149. doi:10.9755/ejfa.2020.v32.i2.2074
    • NLM

      Paula CM de, Santos KMO dos, Oliveira LS, Oliveira J da S, Buriti FCA, Saad SMI. Fat substitution by inulin in goat milk ice cream produced with cajá (Spondias mombin) pulp and probiotic cultures: influence on composition, texture, and acceptability among consumers of two Brazilian regions [Internet]. Emirates Journal of Food and Agriculture. 2020 ; 32 n. 2 140-149.[citado 2024 ago. 27 ] Available from: https://doi.org/10.9755/ejfa.2020.v32.i2.2074
    • Vancouver

      Paula CM de, Santos KMO dos, Oliveira LS, Oliveira J da S, Buriti FCA, Saad SMI. Fat substitution by inulin in goat milk ice cream produced with cajá (Spondias mombin) pulp and probiotic cultures: influence on composition, texture, and acceptability among consumers of two Brazilian regions [Internet]. Emirates Journal of Food and Agriculture. 2020 ; 32 n. 2 140-149.[citado 2024 ago. 27 ] Available from: https://doi.org/10.9755/ejfa.2020.v32.i2.2074
  • Source: Mini-Reviews in Medicinal Chemistry. Unidade: FCF

    Subjects: ZIKA VÍRUS, SAÚDE PÚBLICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RAMPINI, Denise et al. Future and perspectives of the Zika Virus: drug repurposing as a powerful tool for treatment insights. Mini-Reviews in Medicinal Chemistry, v. 20, p. 1917-1928, 2020Tradução . . Disponível em: https://doi.org/10.2174/1389557520666200711174007. Acesso em: 27 ago. 2024.
    • APA

      Rampini, D., Prieto, D. C., Colzi, A. L., Araujo, R. V. de, & Giarolla, J. (2020). Future and perspectives of the Zika Virus: drug repurposing as a powerful tool for treatment insights. Mini-Reviews in Medicinal Chemistry, 20, 1917-1928. doi:10.2174/1389557520666200711174007
    • NLM

      Rampini D, Prieto DC, Colzi AL, Araujo RV de, Giarolla J. Future and perspectives of the Zika Virus: drug repurposing as a powerful tool for treatment insights [Internet]. Mini-Reviews in Medicinal Chemistry. 2020 ; 20 1917-1928.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1389557520666200711174007
    • Vancouver

      Rampini D, Prieto DC, Colzi AL, Araujo RV de, Giarolla J. Future and perspectives of the Zika Virus: drug repurposing as a powerful tool for treatment insights [Internet]. Mini-Reviews in Medicinal Chemistry. 2020 ; 20 1917-1928.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1389557520666200711174007
  • Source: Letters in Drug Design and Discovery. Unidades: FCF, ICB

    Subjects: APOPTOSE, NEOPLASIAS MAMÁRIAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FERNANDES, Thais Batista et al. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells. Letters in Drug Design and Discovery, v. 15, n. 12, p. 1288-1298, 2018Tradução . . Disponível em: https://doi.org/10.2174/1570180815666180321161513. Acesso em: 27 ago. 2024.
    • APA

      Fernandes, T. B., Azevedo, R. A. de, Yang, R., Teixeira, S. F., Trossini, G. H. G., Barbuto, J. A. M., et al. (2018). Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells. Letters in Drug Design and Discovery, 15( 12), 1288-1298. doi:10.2174/1570180815666180321161513
    • NLM

      Fernandes TB, Azevedo RA de, Yang R, Teixeira SF, Trossini GHG, Barbuto JAM, Ferreira AK, Parise Filho R. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells [Internet]. Letters in Drug Design and Discovery. 2018 ; 15( 12): 1288-1298.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1570180815666180321161513
    • Vancouver

      Fernandes TB, Azevedo RA de, Yang R, Teixeira SF, Trossini GHG, Barbuto JAM, Ferreira AK, Parise Filho R. Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells [Internet]. Letters in Drug Design and Discovery. 2018 ; 15( 12): 1288-1298.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1570180815666180321161513
  • Source: Anti-Cancer Agents in Medicinal Chemistry. Unidades: ICB, FCF

    Subjects: FARMACOLOGIA, IMUNOLOGIA, QUIMIOTERÁPICOS, NEOPLASIAS PULMONARES, SISTEMA IMUNE, FOSFOLIPÍDEOS, PACIENTES, CITOMETRIA DE FLUXO, CITOTOXICIDADE IMUNOLÓGICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TEIXEIRA, Sarah Fernandes et al. Edelfosine: an antitumor drug prototype. Anti-Cancer Agents in Medicinal Chemistry, v. 18, n. 6, p. 865-874, 2018Tradução . . Disponível em: https://doi.org/10.2174/1871520618666180105165431. Acesso em: 27 ago. 2024.
    • APA

      Teixeira, S. F., Rodrigues, C. P., Costa, C. J. S., Pettinati, T. N., Azevedo, R. A. de, Mambelli, L. I., et al. (2018). Edelfosine: an antitumor drug prototype. Anti-Cancer Agents in Medicinal Chemistry, 18( 6), 865-874. doi:10.2174/1871520618666180105165431
    • NLM

      Teixeira SF, Rodrigues CP, Costa CJS, Pettinati TN, Azevedo RA de, Mambelli LI, Jorge SD, Ramos RN, Ferro ES, Barbuto JAM, Ferreira AK. Edelfosine: an antitumor drug prototype [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2018 ; 18( 6): 865-874.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1871520618666180105165431
    • Vancouver

      Teixeira SF, Rodrigues CP, Costa CJS, Pettinati TN, Azevedo RA de, Mambelli LI, Jorge SD, Ramos RN, Ferro ES, Barbuto JAM, Ferreira AK. Edelfosine: an antitumor drug prototype [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2018 ; 18( 6): 865-874.[citado 2024 ago. 27 ] Available from: https://doi.org/10.2174/1871520618666180105165431

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024